Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis

This study tests whether empagliflozin — a diabetes drug that also reduces inflammation — can help treat mild to moderate ulcerative colitis (UC), a chronic inflammatory bowel disease affecting the large intestine. **You may be eligible if...** - You have mild to moderate ulcerative colitis diagnosed by history, clinical signs, and confirmed by endoscopy and biopsy - Your UC severity is classified according to the Montreal classification **You may NOT be eligible if...** - You have Crohn's disease or another inflammatory bowel disease - You have a known serious allergy to empagliflozin - You are on dialysis or have severe kidney impairment (eGFR below 20 mL/min/1.73m²) - You have chronic urinary tract infections or chronic genital infections Talk to your doctor to see if this trial is right for you.